TheStreet Ratings team rates Yamana Gold Inc. (USA) (NYSE:AUY) as a Sell with a ratings score of D+. TheStreet Ratings Team has this to say about their recommendation: We rate YAMANA GOLD INC (AUY) a SELL. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. Yamana Gold Inc. (USA) (NYSE:AUY) shares after opening at $8.38 moved to $8.40 on last trade day and at the end of the day closed at $8.02. Company price to sales ratio in past twelve months was calculated as 3.29 and price to cash ratio as 22.95. Yamana Gold Inc. (USA) (NYSE:AUY) showed a negative weekly performance of -9.17%.
Gordmans Stores (NASDAQ:GMAN) CMO Michael Morand sold 8,000 shares of Gordmans Stores stock on the open market in a transaction dated Thursday, March 27th. The stock was sold at an average price of $5.66, for a total transaction of $45,280.00. Following the completion of the transaction, the chief marketing officer now directly owns 85,358 shares in the company, valued at approximately $483,126. Gordmans Stores, Inc. (NASDAQ:GMAN) shares fell -1.80% in last trading session and ended the day on $4.36. GMAN return on equity ratio is recorded as 10.70% and its return on assets is 3.40%. Gordmans Stores, Inc. (NASDAQ:GMAN) yearly performance is -47.97%.
The Oi SA (ADR) (NYSE:OIBR) on Apr. 3 announces to its shareholders and the market in general that it filed the preliminary prospectus supplement relating to the Offering with the U.S. Securities and Exchange Commission on the date hereof. The Offering may initially consist of 1,917,028,657 common shares and 3,834,057,315 preferred shares, totaling 5,751,085,972 shares, including shares in the form of American Depositary Shares, represented by American Depositary Receipts. The number of shares initially offered, not considering the exercise of the Hot Issue, may be increased, at the option of the lead coordinator, by up to 15%, or 287,554,298 common shares and 575,108,597 preferred shares, totaling 862,662,895 shares, in order to fulfill subsequent demand for the Offering. Oi SA (ADR) (NYSE:OIBR) shares was closed at $1.15, while trading in range of $1.09-$1.15. Oi SA (ADR) (NYSE:OIBR) year to date performance is -27.67%.
In a report published Tuesday, MLV & Co analyst Graig C. Suvannavejh downgraded the rating on Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) from Buy to Hold, and lowered the price target from $11.00 to $3.00. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) weekly performance is -18.31%. On last trading day company shares ended up $1.74. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) distance from 50-day simple moving average is -78.64%. Analysts mean target price for the company is $4.00.